Chart calendar Gilead Sciences, Inc.

edf19f01d3e81d61d.sBCazealZr4wicJHGHtYdJpP8G4I72FTiTKSsV1jtbA.iXbP_LzOMvtE0KVzaRESFf8smV1bsC4L3wHq5DcR-YLfKOKZregg8lP6-g~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2025-08-04 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)
2026-02-09 Q4 2025 Earnings Release (Projected)
2026-04-22 Q1 2026 Earnings Release (Projected)

Past events on Gilead Sciences, Inc.

2025-06-14 11:00 European Hematology Association Congress - Abstract No: #S201
2025-06-13 12:30 European Hematology Association Congress - Abstract No: #PF374
2025-06-13 12:30 European Hematology Association Congress - Abstract No: #PF1002
2025-06-13 12:30 European Hematology Association Congress - Abstract No: #PF1168
2025-06-13 12:30 European Hematology Association Congress - Abstract No: #PF1304
2025-06-13 12:30 European Hematology Association Congress - Abstract No: #PF1294
2025-06-13 11:00 European Hematology Association Congress - Abstract No: #S237
2025-06-12 Détachement de
2025-06-10 11:30 Goldman Sachs Global Healthcare Conference
2025-06-04 11:05 Jefferies Healthcare Conference
2025-06-01 10:00 American Society of Clinical Oncology Meeting - Abstract No: #7023
2025-06-01 10:00 American Society of Clinical Oncology Meeting - Abstract No: #7024
2025-06-01 09:12 American Society of Clinical Oncology Meeting - Abstract No: #511
2025-05-31 17:12 American Society of Clinical Oncology Meeting - Abstract No: #2020
2025-05-31 16:35 American Society of Clinical Oncology Meeting - Abstract No: #LBA109
2025-05-31 14:30 American Society of Clinical Oncology Meeting - Abstract No: #8599
2025-05-31 14:30 American Society of Clinical Oncology Meeting - Abstract No: #11154
2025-05-31 10:00 American Society of Clinical Oncology Meeting - Abstract No: #4033
2025-05-30 16:45 American Society of Clinical Oncology Meeting - Abstract No: #7003
2025-05-29 14:30 Bernstein Strategic Decisions Conference

Past dividends on Gilead Sciences, Inc.

2025-06-12 Quarterly 0.79 USD
2025-03-13 Quarterly 0.79 USD
2024-12-12 Quarterly 0.77 USD
2024-09-12 Quarterly 0.77 USD
2024-06-13 Quarterly 0.77 USD
2024-03-13 Quarterly 0.77 USD
2023-12-13 Quarterly 0.75 USD
2023-09-13 Quarterly 0.75 USD
2023-06-13 Quarterly 0.75 USD
2023-03-13 Quarterly 0.75 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.73 USD
2022-06-13 Quarterly 0.73 USD
2022-03-13 Quarterly 0.73 USD
2021-12-13 Quarterly 0.71 USD
2021-09-13 Quarterly 0.71 USD
2021-06-13 Quarterly 0.71 USD
2021-03-11 Quarterly 0.71 USD
2020-12-13 Quarterly 0.68 USD
2020-09-13 Quarterly 0.68 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
27 281
26 518
2.88%
27 116
27 083
0.12%
28 754
28 310
1.57%

28 675


29 749


31 253

EBITDA
Million USD
Released
Forecast
Spread
14 283
13 783
3.63%
13 177
13 123
0.41%
11 287
10 600
6.49%

15 708


16 209


17 328

EBIT
Million USD
Released
Forecast
Spread
12 180
12 141
0.32%
10 484
10 687
-1.9%
8 520
8 238
3.42%

13 005


13 710


14 560

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 814
5 658
2.76%
6 859
7 323
-6.33%
690
498
38.57%

9 181


10 370


11 038

Net income
Million USD
Released
Forecast
Spread
4 592
4 383
4.77%
5 665
5 872
-3.52%
480
282
70.44%

7 432


8 466


9 243

EPS
USD
Released
Forecast
Spread
3,64
3,48
4.75%
4,50
4,69
-3.96%
0,38
0,10
274.46%

6,03


6,87


7,49

Announcement Date02/02/2306/02/2411/02/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
7 051
6 800
3.69%
7 115
7 104
0.16%
6 686
6 349
5.31%
6 954
6 735
3.25%
7 545
6 999
7.8%
7 569
7 154
5.8%
6 667
6 813
-2.14%

6 954


7 395


7 576


6 958


7 201


7 623


7 983

EBITDA
Million USD
Released
Forecast
Spread
3 908
3 636
7.49%
3 427
3 495
-1.94%
-427
-889
51.98%
3 959
3 365
17.67%
3 948
3 498
12.86%
3 807
3 255
16.94%
3 589
3 423
4.85%

3 997


4 211


4 171


3 852


4 029


4 349


4 360

EBIT
Million USD
Released
Forecast
Spread
3 224
3 060
5.37%
2 739
2 940
-6.84%
-1 117
-1 679
33.48%
3 265
2 739
19.18%
3 258
2 721
19.75%
3 114
2 876
8.27%
2 893
2 830
2.22%

3 199


3 540


3 371


3 145


3 284


3 609


3 808

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2 318
2 275
1.91%
1 653
2 090
-20.89%
-4 486


2 053
1 733
18.45%
956
1 652
-42.12%
2 168
2 043
6.14%
1 649
2 068
-20.24%

2 334


2 713


2 503


2 507


2 701


3 139


2 823

Net income
Million USD
Released
Forecast
Spread
2 180
1 801
21.07%
1 429
1 599
-10.66%
-4 170
-2 888
-44.38%
1 614
1 379
17.02%
1 253
1 335
-6.15%
1 783
1 605
11.1%
1 315
1 533
-14.2%

1 881


2 148


2 066


1 961


2 113


2 406


2 280

EPS
USD
Released
Forecast
Spread
1,73
1,43
20.88%
1,14
1,28
-11.05%
-3,34
-1,92
-74.06%
1,29
1,13
14.13%
1,00
1,08
-7.48%
1,42
1,19
19.08%
1,04
1,26
-17.75%

1,47


1,72


1,65


1,48


1,62


1,85


1,81

Announcement Date07/11/2306/02/2425/04/2408/08/2406/11/2411/02/2524/04/25-------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.